CastellvÃ, M.; Felip, E.; Ezeonwumelu, I.J.; Badia, R.; Garcia-Vidal, E.; Pujantell, M.; Gutiérrez-Chamorro, L.; Teruel, I.; MartÃnez-Cardús, A.; Clotet, B.;
et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.
https://doi.org/10.3390/cancers12030713
AMA Style
Castellvà M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, MartÃnez-Cardús A, Clotet B,
et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers. 2020; 12(3):713.
https://doi.org/10.3390/cancers12030713
Chicago/Turabian Style
CastellvÃ, Marc, Eudald Felip, Ifeanyi Jude Ezeonwumelu, Roger Badia, Edurne Garcia-Vidal, Maria Pujantell, LucÃa Gutiérrez-Chamorro, Iris Teruel, Anna MartÃnez-Cardús, Bonaventura Clotet,
and et al. 2020. "Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy" Cancers 12, no. 3: 713.
https://doi.org/10.3390/cancers12030713
APA Style
CastellvÃ, M., Felip, E., Ezeonwumelu, I. J., Badia, R., Garcia-Vidal, E., Pujantell, M., Gutiérrez-Chamorro, L., Teruel, I., MartÃnez-Cardús, A., Clotet, B., Riveira-Muñoz, E., MargelÃ, M., Esté, J. A., & Ballana, E.
(2020). Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers, 12(3), 713.
https://doi.org/10.3390/cancers12030713